{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Flong-acting-cabotegravir-for-hiv-prevention-RqoXtGGx","width":444,"version":"1.0","type":"rich","title":"Long-Acting Cabotegravir for HIV Prevention","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/6f402e9a-eac4-455d-8334-2996f9c0edae/6c8813f8-1490-402f-b2ec-ba815d8275d8/cliniciansxchange-id-podcast-la-prep-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/995b8ea5-6008-4a21-9311-bda7f7c8649a\" height=\"200\" width=\"100%\" title=\"Long-Acting Cabotegravir for HIV Prevention\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"This podcast episode features an international expert panel discussion on key considerations for using long-acting cabotegravir as HIV PrEP. "}